RNA Cure Overview
- Year Founded
-
2019
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
- Investors
-
9
RNA Cure General Information
Description
Developer of nucleic acid-based therapeutics designed for the treatment of severe diseases. The company offers early-stage target discovery and scalable development capabilities, incorporates proprietary delivery technologies, supports preclinical validation, and leverages a team with extensive academic research experience, enabling the biomedical sector to accelerate novel drug development and improve therapeutic precision.
Contact Information
Website
www.rnacure.comCorporate Office
- Floors 7-9, Building C7, Bay Valley Science and Technology Park
- Yangpu District
- Shanghai, 200438
- China
Corporate Office
- Floors 7-9, Building C7, Bay Valley Science and Technology Park
- Yangpu District
- Shanghai, 200438
- China
RNA Cure Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Secondary Transaction - Private | 26-Jun-2026 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 30-May-2024 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 23-May-2022 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 21-Dec-2021 | Completed | Generating Revenue | |||
| 3. Secondary Transaction - Private | 19-Oct-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC | 27-Sep-2021 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 29-Mar-2021 | Completed | Generating Revenue |
RNA Cure Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
RNA Cure Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| CASH Capital | Venture Capital | Minority | ||
| Co-Stone Capital | PE/Buyout | Minority | ||
| Guoxin Venture Capital Management (Shenzhen) | Growth/Expansion | Minority | ||
| Shanghai Jizi Investment Management | Growth/Expansion | Minority | ||
| 3E Bioventures (China) | Venture Capital | Minority |
RNA Cure FAQs
-
When was RNA Cure founded?
RNA Cure was founded in 2019.
-
Where is RNA Cure headquartered?
RNA Cure is headquartered in Shanghai, China.
-
What industry is RNA Cure in?
RNA Cure’s primary industry is Biotechnology.
-
Is RNA Cure a private or public company?
RNA Cure is a Private company.
-
What is RNA Cure’s current revenue?
The current revenue for RNA Cure is .
-
Who are RNA Cure’s investors?
CASH Capital, Co-Stone Capital, Guoxin Venture Capital Management (Shenzhen), Shanghai Jizi Investment Management, and 3E Bioventures (China) are 5 of 9 investors who have invested in RNA Cure.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
